Position in ANIP
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,783,477
New position
Shares Held
33,625
first reported quarter
Ownership
0.146%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#93
of 305 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 54%
Shared 0%
None 46%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bridge City Capital, LLC holds $24,367,503 across 5 Drug Manufacturers - Specialty & Generic names. ANIP ranks #5 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCRX |
Pacira BioSciences, Inc.
|
312,297 | $7,922,974 | |
| 2 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
338,708 | $6,835,127 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
78,167 | $3,635,547 | |
| 4 | ETON |
Eton Pharmaceuticals, Inc.
|
88,132 | $3,190,378 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
This page
|
33,625 | $2,783,477 |
All Filings in ANIP
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,783,477 | 33,625 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||